DE3689598T2 - Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren. - Google Patents

Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren.

Info

Publication number
DE3689598T2
DE3689598T2 DE3689598T DE3689598T DE3689598T2 DE 3689598 T2 DE3689598 T2 DE 3689598T2 DE 3689598 T DE3689598 T DE 3689598T DE 3689598 T DE3689598 T DE 3689598T DE 3689598 T2 DE3689598 T2 DE 3689598T2
Authority
DE
Germany
Prior art keywords
polypeptide
gene
cecropin
arab
heterologous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3689598T
Other languages
German (de)
English (en)
Other versions
DE3689598D1 (de
Inventor
Jiunu Lai
Jar-How Lee
Yun-Long Lin
Dan Ray
Gary Wilcox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Royalty Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of DE3689598D1 publication Critical patent/DE3689598D1/de
Publication of DE3689598T2 publication Critical patent/DE3689598T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE3689598T 1985-01-28 1986-01-24 Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren. Expired - Lifetime DE3689598T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69530985A 1985-01-28 1985-01-28
US79747285A 1985-11-13 1985-11-13
PCT/US1986/000131 WO1986004356A1 (en) 1985-01-28 1986-01-24 AraB PROMOTERS AND METHOD OF PRODUCING POLYPEPTIDES, INCLUDINN CECROPINS, BY MICROBIOLOGICAL TECHNIQUES

Publications (2)

Publication Number Publication Date
DE3689598D1 DE3689598D1 (de) 1994-03-17
DE3689598T2 true DE3689598T2 (de) 1994-06-30

Family

ID=27105550

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3689598T Expired - Lifetime DE3689598T2 (de) 1985-01-28 1986-01-24 Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren.
DE3650625T Expired - Fee Related DE3650625T2 (de) 1985-01-28 1986-01-24 AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3650625T Expired - Fee Related DE3650625T2 (de) 1985-01-28 1986-01-24 AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren

Country Status (8)

Country Link
EP (2) EP0211047B1 (https=)
JP (2) JPH082308B2 (https=)
KR (1) KR870700095A (https=)
AT (2) ATE101203T1 (https=)
DE (2) DE3689598T2 (https=)
FI (1) FI94774C (https=)
NO (1) NO175870C (https=)
WO (1) WO1986004356A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166321A (en) * 1985-01-28 1992-11-24 International Genetic Engineering, Inc. Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria
US5028530A (en) * 1985-01-28 1991-07-02 Xoma Corporation AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
EP0590301A2 (en) * 1986-07-25 1994-04-06 Louisiana State University and Agricultural and Mechanical College Method for protecting plants from disease and infestation by gene insertion, and vectors and plant cells containing said genes
US5597945A (en) * 1986-07-25 1997-01-28 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Plants genetically enhanced for disease resistance
DE3716957A1 (de) * 1987-05-20 1988-12-01 Boehringer Mannheim Gmbh Expressionsvektor zur regulierbaren expression von fremdgenen in prokaryonten
CA1327311C (en) 1987-07-06 1994-03-01 Jesse M. Jaynes Therapeutic antimicrobial polypeptides, their use and methods for preparation
US5861478A (en) 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
KR970006154B1 (ko) * 1987-07-06 1997-04-24 루이지아나 스테이트 유니버시티 아그리컬춰럴 앤드 메카니칼 컬리지 용해성 펩티드에 의한 진핵 병원체와 신생물의 억제 및 섬유아세포와 임파구의 자극
EP0326419A3 (en) * 1988-01-27 1991-09-25 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE Vaccines for the protection of animals against hypodermosis
US5631007A (en) * 1990-03-12 1997-05-20 Ciba-Geigy Corporation Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes
PH30997A (en) * 1990-03-12 1997-12-23 Ciba Geigy Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
IL114697A0 (en) * 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
WO1998011231A1 (en) * 1996-09-10 1998-03-19 The Rockefeller University Highly regulable promoter for heterologous gene expression
JP2003524018A (ja) 2000-02-24 2003-08-12 アイトゲネーシシェ テクニシェ ホッホシューレ チューリッヒ フィブロネクチンのｅｄ‐ｂドメインに特異的な抗体、前記抗体を含む複合体、および血管形成を検出および治療するためのその使用
ATE466090T1 (de) 2004-12-07 2010-05-15 Lonza Ag Rhamnosepromotor-expressionssystem
EP2934532B1 (en) 2012-12-20 2019-10-23 Purdue Research Foundation Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
JP7282521B2 (ja) 2016-04-08 2023-05-29 パーデュー・リサーチ・ファウンデイション Ｃａｒ ｔ細胞療法のための方法および組成物
CN110612119B (zh) 2017-02-07 2024-10-29 西雅图儿童医院（Dba西雅图儿童研究所） 磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂
JP7178355B2 (ja) 2017-02-28 2022-11-25 エンドサイト・インコーポレイテッド Ｃａｒ ｔ細胞療法のための組成物および方法
JP7549303B2 (ja) 2018-01-22 2024-09-11 エンドサイト・インコーポレイテッド Ｃａｒ ｔ細胞の使用方法
SG11202007426XA (en) 2018-02-06 2020-09-29 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
CN112105382A (zh) 2018-02-23 2020-12-18 恩多塞特公司 用于car t细胞疗法的顺序方法
AU2021217003A1 (en) 2020-02-04 2022-09-15 Seattle Children's Hospital (dba Seattle Children's Research Institute) Anti-dinitrophenol chimeric antigen receptors
CN112575047B (zh) * 2020-12-29 2024-06-21 中农颖泰林州生物科园有限公司 一种提高饲料用的抗菌肽天蚕素收率的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4335104A (en) * 1978-08-16 1982-06-15 United Chemical Corporation Anhydrous multi-purpose moisturizing composition
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4355104A (en) 1980-06-17 1982-10-19 Kabigen Ab Bacteriolytic proteins
US4520016A (en) * 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
IL68561A (en) 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
WO1985001746A1 (en) 1983-10-11 1985-04-25 Beatrice Companies, Inc. The manufacture and expression of genes for thaumatin

Also Published As

Publication number Publication date
FI94774C (fi) 1995-10-25
EP0211047A4 (en) 1989-04-24
FI863891A0 (fi) 1986-09-26
ATE153377T1 (de) 1997-06-15
DE3650625T2 (de) 1997-10-02
WO1986004356A1 (en) 1986-07-31
EP0460709B1 (en) 1997-05-21
DE3650625D1 (de) 1997-06-26
JPH082308B2 (ja) 1996-01-17
JPH0829112B2 (ja) 1996-03-27
JPH0767684A (ja) 1995-03-14
NO175870B (https=) 1994-09-12
JPS62501538A (ja) 1987-06-25
EP0211047A1 (en) 1987-02-25
ATE101203T1 (de) 1994-02-15
FI94774B (fi) 1995-07-14
NO175870C (no) 1994-12-21
EP0211047B1 (en) 1994-02-02
EP0460709A1 (en) 1991-12-11
NO863806D0 (no) 1986-09-24
FI863891L (fi) 1986-09-26
KR870700095A (ko) 1987-02-28
NO863806L (no) 1986-11-19
DE3689598D1 (de) 1994-03-17

Similar Documents

Publication Publication Date Title
DE3689598T2 (de) Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren.
US5357044A (en) Cecropins fusion proteins
US5206154A (en) Method of producing cecropins by microbiological techniques
DE3280422T2 (de) Verfahren und produkte zur leichten mikrobiologischen expression von dns-sequenzen.
DE3650553T2 (de) Verfahren zur Herstellung biologisch aktiver Rinder- und Schweine-Wachstumshormone und Mischung mit biologisch aktivem Schweine-Wachstumshormon
DE69233008T2 (de) Fusionierung von Peptiden und Proteinen mit Thioredoxin und thioredoxin-ähnlichen Molekülen
DE3689846T2 (de) Erhöhte ausscheidung von heterologen proteinen durch wirtszellen durch verwendung von substituierten promotoren.
DE3486216T2 (de) Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.
DE69636996T2 (de) Methoden und zusammensetzungen für die sekretion von heterologen polypeptiden
DE3650664T2 (de) Verwendung von promotoren von filamentösen pilzen
EP0099084A2 (de) Verfahren zur Herstellung von Interferon und Expressionsvektoren dafür
DE3382575T2 (de) Dna-sequenzen, rekombinante dna-molekuele und verfahren zur herstellung von schweinewachstumshormonaehnlichen polypeptiden.
DE3853748T2 (de) Polypeptide mit aktivität gegen gram-positive und gram-negative bakterien.
DD297188A5 (de) Gm-csf und il-3 umfassende fusionsproteine
DD210304A5 (de) Verfahren zur herstellung eines replikablen vektors
DE2848052A1 (de) Synthetische dna und verfahren zu ihrer herstellung
DE2848053A1 (de) Synthetische dna und verfahren zu ihrer herstellung
DD212982A5 (de) Verfahren zur herstellung von rinder-wachstumshormon-aehnlichen polypeptiden
DE3587875T2 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
JPH09110899A (ja) 微生物によるヒト副甲状腺ホルモンの生産
DE60224930T2 (de) Expressionsvektoren die signalpeptide aus bakteriophagen kodieren
DE3320339C2 (https=)
DE3687112T2 (de) Verfahren zur ausscheidung von genprodukten in das wachstumsmedium von gram-negativen bakterien.
DE3882247T2 (de) Verfahren zur Expressionsregulation eines Fremdgens mittels Kontrolle der Zuckerkonzentration in einem Medium und Verfahren zur Herstellung eines Fremdgenproduktes.
DE3850410T2 (de) cDNS KODIEREND FÜR SOMATOTROPIN, EXPRESSIONSVEKTOREN UND -WIRTE.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition